The murine receptor for urokinase-type plasminogen activator is primarily expressed in tissues actively undergoing remodeling
- PMID: 11156692
- DOI: 10.1177/002215540104900211
The murine receptor for urokinase-type plasminogen activator is primarily expressed in tissues actively undergoing remodeling
Abstract
uPAR is a cellular receptor for urokinase plasminogen activator, an enzyme involved in extracellular matrix degradation during processes involving tissue remodeling. We have expressed a recombinant soluble form of murine uPAR and raised rabbit polyclonal antibodies to study the expression of uPAR by immunohistochemistry. The immunohistochemical localization of uPAR was determined in normal mouse organs and in tumors formed by the highly metastatic Lewis lung carcinoma. uPAR immunoreactivity was found in the lungs, kidneys, and spleen, and in endothelial cells in the uterus, urinary bladder, thymus, heart, liver, and testis. No uPAR immunoreactivity was detected in muscle. In general, strong uPAR immunoreactivity was observed in organs undergoing extensive tissue remodeling, as exemplified by trophoblast cells in placenta, and in migrating, but not resting, keratinocytes at the edge of incisional wounds. Staining was not detected in any tissue sections derived from uPAR-deficient mice, thus confirming the specificity of the immunohistochemical staining of uPAR in normal mouse tissues. In Lewis lung carcinoma, uPAR immunoreactivity was found in the tumor cells of the primary tumor and in lung metastases. (J Histochem Cytochem 49:237-246, 2001)
Similar articles
-
A cleaved form of the receptor for urokinase-type plasminogen activator in invasive transplanted human and murine tumors.Int J Cancer. 1994 Sep 15;58(6):877-81. doi: 10.1002/ijc.2910580622. Int J Cancer. 1994. PMID: 7927882
-
Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non small cell lung carcinoma.Int J Cancer. 2003 Jun 20;105(3):353-60. doi: 10.1002/ijc.11091. Int J Cancer. 2003. PMID: 12704669
-
Expression of the human urokinase-type plasminogen activator receptor in E. coli and Chinese hamster ovary cells: purification of the recombinant proteins and generation of polyclonal antibodies in chicken.Electrophoresis. 1995 May;16(5):813-6. doi: 10.1002/elps.11501601134. Electrophoresis. 1995. PMID: 7588568
-
Urokinase receptor variants in tissue and body fluids.Adv Clin Chem. 2007;44:65-102. Adv Clin Chem. 2007. PMID: 17682340 Review.
-
The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodeling.Biol Chem. 2004 Feb;385(2):103-36. doi: 10.1515/BC.2004.031. Biol Chem. 2004. PMID: 15101555 Review.
Cited by
-
DOT corrected fluorescence molecular tomography using targeted contrast agents for small animal tumor imaging.J Xray Sci Technol. 2013;21(1):43-52. doi: 10.3233/XST-130365. J Xray Sci Technol. 2013. PMID: 23507851 Free PMC article.
-
Influence of the plasminogen activator system on necrosis in acute myocardial infarction: analysis of urokinase- and urokinase receptor-knockout mouse models.Am J Transl Res. 2019 Jun 15;11(6):3629-3636. eCollection 2019. Am J Transl Res. 2019. PMID: 31312373 Free PMC article.
-
Generation and Characterization of Novel Pan-Cancer Anti-uPAR Fluorescent Nanobodies as Tools for Image-Guided Surgery.Adv Sci (Weinh). 2024 Aug;11(30):e2400700. doi: 10.1002/advs.202400700. Epub 2024 Jun 6. Adv Sci (Weinh). 2024. PMID: 38845188 Free PMC article.
-
Targeting uPAR with an antibody-drug conjugate suppresses tumor growth and reshapes the immune landscape in pancreatic cancer models.Sci Adv. 2025 Jan 17;11(3):eadq0513. doi: 10.1126/sciadv.adq0513. Epub 2025 Jan 17. Sci Adv. 2025. PMID: 39823326 Free PMC article.
-
Development of Receptor Targeted Magnetic Iron Oxide Nanoparticles for Efficient Drug Delivery and Tumor Imaging.J Biomed Nanotechnol. 2008 Dec 1;4(4):439-449. doi: 10.1166/jbn.2008.007. J Biomed Nanotechnol. 2008. PMID: 25152701 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources